On June 15th, 2019 there was a preliminary study into the effects of McLoughlin Scar Tissue Release® (MSTR®) on Caesarean Section scars which was conducted at The Newcastle Clinic, Newcastle, UK with Consultant Radiologist Dr Peddada Raju.
A General Electric (GE) Soniq S8 ultrasound scanner was used to conduct the test on three test subjects with C-section scars. Each subject was pre-scanned and images including size and depth of scar tissue and the amount of vascularity both surrounding and within the scar were recorded. MSTR work was then applied for a total of 15 minutes per subject, as a single treatment. Immediately after MSTR treatment each subject underwent a post-treatment ultrasound scan conducted by Dr Raju.
All three subjects were shown to have decreased scar tissue in the post treatment scan. One example of improvement was of a scar that was initially measured at 31.5mm pre treatment. The scar was re-measured at just 18.1mm post treatment. Another example was that of a longitudinal scar reducing in size from 22.7mm pre-treatment to just 10.4mm post-treatment. An increase in vascularity was noted not only in the surrounding tissue but also actually through the scar. Interestingly it should be noted that NO vascularity was present in the pre-scan of the same area.
This initial work confirms the claim that MSTR helps open the densely bound collagen fibres that make up scar tissue to allow increased blood flow into the area once again. This preliminary work will be followed by a larger study that will be undertaken at ‘The Newcastle’ later in 2019.
Read Charlotte's story.